S&P 500   3,962.19 (-0.03%)
DOW   33,719.25 (-0.18%)
QQQ   284.06 (+0.07%)
AAPL   144.11 (+1.02%)
MSFT   246.82 (-0.23%)
META   116.75 (+1.23%)
GOOGL   93.46 (-0.27%)
AMZN   89.22 (-1.25%)
TSLA   179.02 (+3.22%)
NVDA   172.43 (+0.43%)
NIO   12.80 (-4.55%)
BABA   92.07 (-2.23%)
AMD   69.53 (-1.33%)
T   19.23 (+0.58%)
MU   55.43 (+0.42%)
CGC   2.94 (-4.85%)
F   13.22 (+0.76%)
GE   82.38 (-1.49%)
DIS   93.95 (+1.51%)
AMC   5.85 (-3.62%)
PYPL   74.17 (-0.07%)
PFE   51.89 (+0.21%)
NFLX   325.75 (+4.99%)
S&P 500   3,962.19 (-0.03%)
DOW   33,719.25 (-0.18%)
QQQ   284.06 (+0.07%)
AAPL   144.11 (+1.02%)
MSFT   246.82 (-0.23%)
META   116.75 (+1.23%)
GOOGL   93.46 (-0.27%)
AMZN   89.22 (-1.25%)
TSLA   179.02 (+3.22%)
NVDA   172.43 (+0.43%)
NIO   12.80 (-4.55%)
BABA   92.07 (-2.23%)
AMD   69.53 (-1.33%)
T   19.23 (+0.58%)
MU   55.43 (+0.42%)
CGC   2.94 (-4.85%)
F   13.22 (+0.76%)
GE   82.38 (-1.49%)
DIS   93.95 (+1.51%)
AMC   5.85 (-3.62%)
PYPL   74.17 (-0.07%)
PFE   51.89 (+0.21%)
NFLX   325.75 (+4.99%)
S&P 500   3,962.19 (-0.03%)
DOW   33,719.25 (-0.18%)
QQQ   284.06 (+0.07%)
AAPL   144.11 (+1.02%)
MSFT   246.82 (-0.23%)
META   116.75 (+1.23%)
GOOGL   93.46 (-0.27%)
AMZN   89.22 (-1.25%)
TSLA   179.02 (+3.22%)
NVDA   172.43 (+0.43%)
NIO   12.80 (-4.55%)
BABA   92.07 (-2.23%)
AMD   69.53 (-1.33%)
T   19.23 (+0.58%)
MU   55.43 (+0.42%)
CGC   2.94 (-4.85%)
F   13.22 (+0.76%)
GE   82.38 (-1.49%)
DIS   93.95 (+1.51%)
AMC   5.85 (-3.62%)
PYPL   74.17 (-0.07%)
PFE   51.89 (+0.21%)
NFLX   325.75 (+4.99%)
S&P 500   3,962.19 (-0.03%)
DOW   33,719.25 (-0.18%)
QQQ   284.06 (+0.07%)
AAPL   144.11 (+1.02%)
MSFT   246.82 (-0.23%)
META   116.75 (+1.23%)
GOOGL   93.46 (-0.27%)
AMZN   89.22 (-1.25%)
TSLA   179.02 (+3.22%)
NVDA   172.43 (+0.43%)
NIO   12.80 (-4.55%)
BABA   92.07 (-2.23%)
AMD   69.53 (-1.33%)
T   19.23 (+0.58%)
MU   55.43 (+0.42%)
CGC   2.94 (-4.85%)
F   13.22 (+0.76%)
GE   82.38 (-1.49%)
DIS   93.95 (+1.51%)
AMC   5.85 (-3.62%)
PYPL   74.17 (-0.07%)
PFE   51.89 (+0.21%)
NFLX   325.75 (+4.99%)

CVS Health - CVS Price Target & Analyst Ratings

$102.39
-0.14 (-0.14%)
(As of 12/9/2022 01:28 PM ET)
Add
Compare
Today's Range
$101.77
$102.57
50-Day Range
$87.84
$102.58
52-Week Range
$86.28
$111.25
Volume
69,188 shs
Average Volume
5.06 million shs
Market Capitalization
$134.54 billion
P/E Ratio
43.57
Dividend Yield
2.15%
Price Target
$118.84

CVS Health Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 19 Analyst Ratings

Consensus Analyst Price Target

$118.84
16.07% Upside
High Prediction$130.00
Average Prediction$118.84
Low Prediction$106.00
TypeCurrent
12/9/21 to 12/9/22
1 Month Ago
11/9/21 to 11/9/22
3 Months Ago
9/10/21 to 9/10/22
1 Year Ago
12/9/20 to 12/9/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
15 Buy rating(s)
16 Buy rating(s)
17 Buy rating(s)
13 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$118.84$118.68$118.35$104.06
Predicted Upside16.07% Upside18.99% Upside18.19% Upside14.56% Upside
Get CVS Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.


CVS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CVS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CVS Health Stock vs. The Competition

TypeCVS HealthRetail/Wholesale CompaniesS&P 500
Consensus Rating Score
2.79
2.41
2.48
Consensus RatingModerate BuyHoldHold
Predicted Upside15.91% Upside94.61% Upside14.86% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1365
77.16%
Underperform Votes
404
22.84%
Avg. Outperform Votes
392
64.69%
Avg. Underperform Votes
214
35.31%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/23/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$124.00 ➝ $119.00+19.59%
11/21/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$117.00 ➝ $125.00+28.40%
11/8/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$111.00 ➝ $106.00+4.76%
11/7/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$119.00 ➝ $115.00+14.90%
11/6/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$120.00 ➝ $115.00+15.51%
11/3/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$130.00 ➝ $125.00+27.55%
11/3/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$128.00 ➝ $113.00+16.60%
10/20/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$122.00 ➝ $118.00+28.74%
9/7/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$120.00 ➝ $125.00+26.61%
8/17/2022Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$125.00 ➝ $130.00+23.69%
8/15/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$115.00 ➝ $120.00+12.79%
8/4/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$118.00 ➝ $127.00+23.65%
8/4/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$113.00 ➝ $120.00+18.37%
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$120.00+33.48%
5/26/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$122.00 ➝ $112.00+14.52%
2/10/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$108.00 ➝ $120.00+14.51%
1/12/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$107.00 ➝ $110.00+3.73%
1/10/2022Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
1/5/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$118.00 ➝ $124.00+17.46%
12/10/2021Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$103.00 ➝ $114.00+16.09%
12/1/2021Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
11/4/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$98.00 ➝ $111.00+15.22%
11/4/2021Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$100.00 ➝ $110.00+14.18%
5/19/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Outperform$82.00 ➝ $93.00+4.95%
5/5/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$90.00 ➝ $95.00+15.35%
3/23/2021Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Neutral
12/14/2020SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform$73.00 ➝ $80.00+11.76%
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$72.00 ➝ $76.00+8.22%
11/9/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Halper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
5/6/2020Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Wiederhorn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/13/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$90.00 ➝ $80.00+32.30%
2/12/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy$85.00 ➝ $86.00+18.19%
(Data available from 12/9/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CVS Price Target - Frequently Asked Questions

What is CVS Health's consensus rating and price target?

According to the issued ratings of 19 analysts in the last year, the consensus rating for CVS Health stock is Moderate Buy based on the current 4 hold ratings and 15 buy ratings for CVS. The average twelve-month price prediction for CVS Health is $118.84 with a high price target of $130.00 and a low price target of $106.00. Learn more on CVS's analyst rating history.

Do Wall Street analysts like CVS Health more than its competitors?

Analysts like CVS Health more than other Retail/Wholesale companies. The consensus rating for CVS Health is Moderate Buy while the average consensus rating for retail/wholesale companies is Hold. Learn more on how CVS compares to other companies.

Do MarketBeat users like CVS Health more than its competitors?

MarketBeat users like CVS Health more than other Retail/Wholesale companies. 77.16% of MarketBeat users gave CVS Health an outperform vote while retail/wholesale companies recieve an average of 64.70% outperform votes by MarketBeat users.

Does CVS Health's stock price have much upside?

According to analysts, CVS Health's stock has a predicted upside of 18.84% based on their 12-month price targets.

What analysts cover CVS Health?

Stock Ratings Reports and Tools

This page (NYSE:CVS) was last updated on 12/9/2022 by MarketBeat.com Staff